MARUY Quote, Financials, Valuation and Earnings

Japan Food Tech Holdings has a net margin of 6.95% compared to Marubeni's net margin of -1471.96%. Marubeni's return on equity of 14.34% beat Japan Food Tech Holdings's return on equity of -241.02%.

Marubeni has a consensus price target of --, signalling downside risk potential of --. On the other hand Japan Food Tech Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Marubeni has higher upside potential than Japan Food Tech Holdings, analysts believe Marubeni is more attractive than Japan Food Tech Holdings.

Marubeni has a beta of 0.879, which suggesting that the stock is 12.078% less volatile than S&P 500. In comparison Japan Food Tech Holdings has a beta of 45.515, suggesting its more volatile than the S&P 500 by 4451.471%.

Marubeni has a quarterly dividend of $3.00 per share corresponding to a yield of 3.84%. Japan Food Tech Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Marubeni pays 29.39% of its earnings as a dividend. Japan Food Tech Holdings pays out -- of its earnings as a dividend. Marubeni's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Marubeni quarterly revenues are $13.2B, which are larger than Japan Food Tech Holdings quarterly revenues of $5.5K. Marubeni's net income of $914.8M is higher than Japan Food Tech Holdings's net income of -$81.3K. Notably, Marubeni's price-to-earnings ratio is 7.73x while Japan Food Tech Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marubeni is 0.52x versus 19.76x for Japan Food Tech Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Kubota has a net margin of 6.95% compared to Marubeni's net margin of 6.75%. Marubeni's return on equity of 14.34% beat Kubota's return on equity of 9.86%.

Marubeni has a consensus price target of --, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 42.71%. Given that Kubota has higher upside potential than Marubeni, analysts believe Kubota is more attractive than Marubeni.

Marubeni has a beta of 0.879, which suggesting that the stock is 12.078% less volatile than S&P 500. In comparison Kubota has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.175%.

Marubeni has a quarterly dividend of $3.00 per share corresponding to a yield of 3.84%. Kubota offers a yield of 2.85% to investors and pays a quarterly dividend of $0.85 per share. Marubeni pays 29.39% of its earnings as a dividend. Kubota pays out 22.85% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Marubeni quarterly revenues are $13.2B, which are larger than Kubota quarterly revenues of $4.7B. Marubeni's net income of $914.8M is higher than Kubota's net income of $317.2M. Notably, Marubeni's price-to-earnings ratio is 7.73x while Kubota's PE ratio is 8.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marubeni is 0.52x versus 0.67x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

Kyocera has a net margin of 6.95% compared to Marubeni's net margin of 7.38%. Marubeni's return on equity of 14.34% beat Kyocera's return on equity of 3.11%.

Marubeni has a consensus price target of --, signalling downside risk potential of --. On the other hand Kyocera has an analysts' consensus of $11.05 which suggests that it could grow by 11.28%. Given that Kyocera has higher upside potential than Marubeni, analysts believe Kyocera is more attractive than Marubeni.

Marubeni has a beta of 0.879, which suggesting that the stock is 12.078% less volatile than S&P 500. In comparison Kyocera has a beta of 0.272, suggesting its less volatile than the S&P 500 by 72.817%.

Marubeni has a quarterly dividend of $3.00 per share corresponding to a yield of 3.84%. Kyocera offers a yield of 3.24% to investors and pays a quarterly dividend of $0.17 per share. Marubeni pays 29.39% of its earnings as a dividend. Kyocera pays out 73.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Marubeni quarterly revenues are $13.2B, which are larger than Kyocera quarterly revenues of $3.2B. Marubeni's net income of $914.8M is higher than Kyocera's net income of $236M. Notably, Marubeni's price-to-earnings ratio is 7.73x while Kyocera's PE ratio is 20.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marubeni is 0.52x versus 1.03x for Kyocera. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of 6.95% compared to Marubeni's net margin of 5.34%. Marubeni's return on equity of 14.34% beat SBC Medical Group Holdings's return on equity of 25.89%.

Marubeni has a consensus price target of --, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of -- which suggests that it could grow by 97.84%. Given that SBC Medical Group Holdings has higher upside potential than Marubeni, analysts believe SBC Medical Group Holdings is more attractive than Marubeni.

Marubeni has a beta of 0.879, which suggesting that the stock is 12.078% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Marubeni has a quarterly dividend of $3.00 per share corresponding to a yield of 3.84%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Marubeni pays 29.39% of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend. Marubeni's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Marubeni quarterly revenues are $13.2B, which are larger than SBC Medical Group Holdings quarterly revenues of $53.1M. Marubeni's net income of $914.8M is higher than SBC Medical Group Holdings's net income of $2.8M. Notably, Marubeni's price-to-earnings ratio is 7.73x while SBC Medical Group Holdings's PE ratio is 12.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marubeni is 0.52x versus 2.56x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.